Drug Profile
Nitric oxide topical - NOLabs
Alternative Names: Nitric oxide-releasing patch - NOLabs; NitroSense PA6; NitroSense® patch - NOLabsLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator NOLabs AB
- Class Anti-infectives; Anti-inflammatories; Antiacnes; Antiandrogens; Antibacterials; Antibronchitics; Antifibrotics; Antifungals; Antihypertensives; Antineoplastics; Antituberculars; Antivirals; Cardiovascular therapies; Diagnostic agents; Foot disorder therapies; Free radicals; Nitrogen oxides; Non-opioid analgesics; Skin disorder therapies; Small molecules; Vascular disorder therapies; Vasodilators
- Mechanism of Action Nitric oxide stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diabetic neuropathies
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Diabetic-neuropathies in India (Topical, Patch)
- 08 Dec 2011 Clinical trials in Diabetic neuropathies in India (Topical)